{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:39:57Z","timestamp":1792784397408,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"DSFP of King Saud University, Riyad, Kingdom of Saudi Arabia","id":[{"id":"https:\/\/ror.org\/02f81g417","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aging Clin Exp Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Osteoarthritis (OA) is a chronic, progressive joint disease characterized by the degradation of articular cartilage, subchondral bone remodeling, synovial inflammation, and osteophyte formation. Despite being a leading cause of disability in older people, effective long-term management of OA remains a significant challenge. Current treatment strategies primarily focus on symptom control, with both non-pharmacological and pharmacological interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>A systematic literature review followed by a structured Delphi survey was conducted, involving an international Technical Expert Panel (TEP) of OA specialists. The panel evaluated the efficacy, safety, and clinical utility of combining low dose diclofenac and chondroitin sulfate in OA management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The analysis of expert consensus indicated that the combination of low dose diclofenac and chondroitin sulfate may be effective in reducing pain and improving joint function in patients with knee OA. Additionally, this combination could reduce the need for higher doses of NSAIDs, thereby minimizing systemic adverse effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The combination of low dose diclofenac and chondroitin sulfate represents a promising therapeutic strategy for managing knee OA. Further studies are needed to confirm these findings and optimize therapeutic strategies to improve patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s40520-025-03221-2","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T14:15:41Z","timestamp":1762438541000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Low dose NSAIDs and sysadoas in the management of knee osteoarthritis"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3397-6478","authenticated-orcid":false,"given":"Alberto","family":"Migliore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2304-6661","authenticated-orcid":false,"given":"Orazio","family":"De Lucia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5541-8346","authenticated-orcid":false,"given":"Alessandro","family":"de Sire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7426-0478","authenticated-orcid":false,"given":"Andrea","family":"\u0160ajbidor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladislav","family":"\u0160enolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5030-6292","authenticated-orcid":false,"given":"S\u00e1ndor","family":"Sz\u00e1nt\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0888-5152","authenticated-orcid":false,"given":"Joan Calvet","family":"Fontova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3392-1124","authenticated-orcid":false,"given":"Johannes","family":"Flechtenmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6261-1286","authenticated-orcid":false,"given":"Ali","family":"Mobasheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9103-661X","authenticated-orcid":false,"given":"Jordi Monfort","family":"Faure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6290-752X","authenticated-orcid":false,"given":"Jean-Yves","family":"Reginster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9328-289X","authenticated-orcid":false,"given":"Nicola","family":"Veronese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"3221_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/S41572-025-00594-6","volume":"11","author":"S Tang","year":"2025","unstructured":"Tang S, Zhang C, Oo WM et al (2025) Osteoarthritis. Nat Rev Dis Primers 11:10. https:\/\/doi.org\/10.1038\/S41572-025-00594-6","journal-title":"Nat Rev Dis Primers"},{"key":"3221_CR2","doi-asserted-by":"publisher","unstructured":"Luo Q, Zhang S, Yang Q et al (2024) Causal factors for osteoarthritis risk revealed by Mendelian randomization analysis. Aging Clin Exp Res 36. https:\/\/doi.org\/10.1007\/S40520-024-02812-9","DOI":"10.1007\/S40520-024-02812-9"},{"key":"3221_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0140-6736(24)02322-5","volume":"405","author":"M Kloppenburg","year":"2025","unstructured":"Kloppenburg M, Namane M, Cicuttini F (2025) Osteoarthr Lancet 405:71\u201385. https:\/\/doi.org\/10.1016\/S0140-6736(24)02322-5","journal-title":"Osteoarthr Lancet"},{"key":"3221_CR4","doi-asserted-by":"publisher","unstructured":"Herrero-Beaumont G, Castro-Dominguez F, Migliore A et al (2024) Systemic osteoarthritis: the difficulty of categorically naming a continuous condition. Aging Clin Exp Res 36. https:\/\/doi.org\/10.1007\/S40520-024-02714-W","DOI":"10.1007\/S40520-024-02714-W"},{"key":"3221_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s40520-024-02883-8","volume":"36","author":"N Veronese","year":"2024","unstructured":"Veronese N, Ragusa FS, Dominguez LJ et al (2024) Mediterranean diet and osteoarthritis: an update. Aging Clin Exp Res 36:231. https:\/\/doi.org\/10.1007\/s40520-024-02883-8","journal-title":"Aging Clin Exp Res"},{"key":"3221_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s40520-025-03015-6","volume":"37","author":"Z Wen","year":"2025","unstructured":"Wen Z, Chen Q, Lan X et al (2025) Physical modalities for the treatment of knee osteoarthritis: a network meta-analysis. Syst Rev Aging Clin Experimental Res 37:121. https:\/\/doi.org\/10.1007\/s40520-025-03015-6","journal-title":"Syst Rev Aging Clin Experimental Res"},{"key":"3221_CR7","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1177\/0363546514533777","volume":"43","author":"B Gallagher","year":"2015","unstructured":"Gallagher B, Tjoumakaris FP, Harwood MI et al (2015) Chondroprotection and the prevention of osteoarthritis progression of the knee: a systematic review of treatment agents. Am J Sports Med 43:734\u2013744. https:\/\/doi.org\/10.1177\/0363546514533777","journal-title":"Am J Sports Med"},{"key":"3221_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/S40520-020-01643-8","volume":"33","author":"JY Reginster","year":"2021","unstructured":"Reginster JY, Veronese N (2021) Highly purified chondroitin sulfate: a literature review on clinical efficacy and Pharmacoeconomic aspects in osteoarthritis treatment. Aging Clin Exp Res 33:37\u201347. https:\/\/doi.org\/10.1007\/S40520-020-01643-8","journal-title":"Aging Clin Exp Res"},{"key":"3221_CR9","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/S40122-023-00531-Z","volume":"12","author":"CLM Trevisan","year":"2023","unstructured":"Trevisan CLM, Carraro A, Baldari GLA (2023) Treatment Satisfaction, Efficacy, and tolerability of Low-Dose diclofenac epolamine soft capsules in Acute, Mild, or moderate musculoskeletal pain: A prospective Open-Label, Single-Arm interventional study. Pain Ther 12:1149\u20131163. https:\/\/doi.org\/10.1007\/S40122-023-00531-Z","journal-title":"Pain Ther"},{"key":"3221_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/J.REUMA.2009.12.009","volume":"6","author":"C Rubio-Terr\u00e9s","year":"2010","unstructured":"Rubio-Terr\u00e9s C (2010) [An economic evaluation of chondroitin sulfate and non-steroidal anti-inflammatory drugs for the treatment of osteoarthritis. Data from the VECTRA study]. Reumatol Clin 6:187\u2013195. https:\/\/doi.org\/10.1016\/J.REUMA.2009.12.009","journal-title":"Reumatol Clin"},{"key":"3221_CR11","doi-asserted-by":"publisher","unstructured":"Sablatzky T (2022) The Delphi method. Hypothesis: Res J Health Inform Professionals 34(2022). https:\/\/doi.org\/10.18060\/26224","DOI":"10.18060\/26224"},{"key":"3221_CR12","doi-asserted-by":"publisher","first-page":"e33898","DOI":"10.2196\/33898","volume":"24","author":"JB Sparks","year":"2022","unstructured":"Sparks JB, Klamerus ML, Caverly TJ et al (2022) Planning and reporting effective Web-Based RAND\/UCLA appropriateness method panels: literature review and preliminary recommendations. J Med Internet Res 24:e33898. https:\/\/doi.org\/10.2196\/33898","journal-title":"J Med Internet Res"},{"key":"3221_CR13","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1016\/J.JOCA.2017.08.009","volume":"25","author":"LA Deveza","year":"2017","unstructured":"Deveza LA, Melo L, Yamato TP et al (2017) Knee osteoarthritis phenotypes and their relevance for outcomes: a systematic review. Osteoarthritis Cartilage 25:1926\u20131941. https:\/\/doi.org\/10.1016\/J.JOCA.2017.08.009","journal-title":"Osteoarthritis Cartilage"},{"key":"3221_CR14","first-page":"64","volume":"37","author":"LA Deveza","year":"2019","unstructured":"Deveza LA, Nelson AE, Loeser RF (2019) Phenotypes of osteoarthritis - current state and future implications. Clin Exp Rheumatol 37:64","journal-title":"Clin Exp Rheumatol"},{"key":"3221_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/BOR.0000000000000353","volume":"29","author":"CR Scanzello","year":"2017","unstructured":"Scanzello CR (2017) Role of low-grade inflammation in osteoarthritis. Curr Opin Rheumatol 29:79\u201385. https:\/\/doi.org\/10.1097\/BOR.0000000000000353","journal-title":"Curr Opin Rheumatol"},{"key":"3221_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s10195-023-00729-z","volume":"24","author":"E Pesare","year":"2023","unstructured":"Pesare E, Vicenti G, Kon E et al (2023) Italian orthopaedic and traumatology society (SIOT) position statement on the non-surgical management of knee osteoarthritis. J Orthop Traumatol 24:47. https:\/\/doi.org\/10.1186\/s10195-023-00729-z","journal-title":"J Orthop Traumatol"},{"key":"3221_CR17","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1136\/ARD.2003.011742","volume":"62","author":"KM Jordan","year":"2003","unstructured":"Jordan KM, Arden NK, Doherty M et al (2003) EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a task force of the standing committee for international clinical studies including therapeutic trials (ESCISIT). Ann Rheum Dis 62:1145\u20131155. https:\/\/doi.org\/10.1136\/ARD.2003.011742","journal-title":"Ann Rheum Dis"},{"key":"3221_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/ACR.24131\/ABSTRACT","volume":"72","author":"SL Kolasinski","year":"2020","unstructured":"Kolasinski SL, Neogi T, Hochberg MC et al (2020) 2019 American college of Rheumatology\/Arthritis foundation guideline for the management of osteoarthritis of the Hand, Hip, and knee. Arthritis Care Res (Hoboken) 72:149\u2013162. https:\/\/doi.org\/10.1002\/ACR.24131\/ABSTRACT","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3221_CR19","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/J.JOCA.2019.06.011","volume":"27","author":"RR Bannuru","year":"2019","unstructured":"Bannuru RR, Osani MC, Vaysbrot EE et al (2019) OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage 27:1578\u20131589. https:\/\/doi.org\/10.1016\/J.JOCA.2019.06.011","journal-title":"Osteoarthritis Cartilage"},{"key":"3221_CR20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/J.SEMARTHRIT.2019.04.008","volume":"49","author":"O Bruy\u00e8re","year":"2019","unstructured":"Bruy\u00e8re O, Honvo G, Veronese N et al (2019) An updated algorithm recommendation for the management of knee osteoarthritis from the European society for clinical and economic aspects of Osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO). Semin Arthritis Rheum 49:337\u2013350. https:\/\/doi.org\/10.1016\/J.SEMARTHRIT.2019.04.008","journal-title":"Semin Arthritis Rheum"},{"key":"3221_CR21","doi-asserted-by":"publisher","first-page":"E721","DOI":"10.5435\/JAAOS-D-21-01233","volume":"30","author":"RH Brophy","year":"2022","unstructured":"Brophy RH, Fillingham YA (2022) AAOS clinical practice guideline summary: management of osteoarthritis of the knee (Nonarthroplasty), third edition. J Am Acad Orthop Surg 30:E721\u2013E729. https:\/\/doi.org\/10.5435\/JAAOS-D-21-01233","journal-title":"J Am Acad Orthop Surg"},{"key":"3221_CR22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1177\/19476035221138958","volume":"14","author":"T Conrozier","year":"2023","unstructured":"Conrozier T, Dira\u00e7ogl\u00f9 D, Monfort J et al (2023) EUROVISCO good practice recommendations for a first viscosupplementation in patients with knee osteoarthritis. Cartilage 14:125\u2013135. https:\/\/doi.org\/10.1177\/19476035221138958","journal-title":"Cartilage"},{"key":"3221_CR23","unstructured":"Overview | Osteoarthritis in over 16s: diagnosis and management | Guidance | NICE"},{"key":"3221_CR24","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1136\/ANNRHEUMDIS-2012-202745","volume":"72","author":"L Fernandes","year":"2013","unstructured":"Fernandes L, Hagen KB, Bijlsma JWJ et al (2013) EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis. Ann Rheum Dis 72:1125\u20131135. https:\/\/doi.org\/10.1136\/ANNRHEUMDIS-2012-202745","journal-title":"Ann Rheum Dis"},{"key":"3221_CR25","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMOA052771\/ASSET\/6840B307-E375-4F2A-875D-878A8A9CE33C\/ASSETS","volume":"354","author":"DO Clegg","year":"2006","unstructured":"Clegg DO, Reda DJ, Harris CL et al (2006) Glucosamine, chondroitin Sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 354:795\u2013808. https:\/\/doi.org\/10.1056\/NEJMOA052771\/ASSET\/6840B307-E375-4F2A-875D-878A8A9CE33C\/ASSETS\/IMAGES\/LARGE\/NEJMOA052771_F3.JPG.","journal-title":"N Engl J Med"},{"key":"3221_CR26","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/S00296-018-4077-2","volume":"38","author":"M Simental-Mend\u00eda","year":"2018","unstructured":"Simental-Mend\u00eda M, S\u00e1nchez-Garc\u00eda A, Vilchez-Cavazos F et al (2018) Effect of glucosamine and chondroitin sulfate in symptomatic knee osteoarthritis: a systematic review and meta-analysis of randomized placebo-controlled trials. Rheumatol Int 38:1413\u20131428. https:\/\/doi.org\/10.1007\/S00296-018-4077-2","journal-title":"Rheumatol Int"},{"key":"3221_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/S40266-019-00662-Z","volume":"36","author":"G Honvo","year":"2019","unstructured":"Honvo G, Reginster JY, Rabenda V et al (2019) Safety of symptomatic Slow-Acting drugs for osteoarthritis: outcomes of a systematic review and Meta-Analysis. Drugs Aging 36:65\u201399. https:\/\/doi.org\/10.1007\/S40266-019-00662-Z","journal-title":"Drugs Aging"},{"key":"3221_CR28","doi-asserted-by":"publisher","first-page":"438","DOI":"10.5414\/CP201641","volume":"50","author":"JL Kienzler","year":"2012","unstructured":"Kienzler JL, Gold M (2012) Diclofenac potassium 12.5\u00a0mg liquid capsules: earlier and higher exposure to diclofenac. A fasted, single-dose, comparative, bioavailability study versus diclofenac potassium 12.5\u00a0mg tablets. Int J Clin Pharmacol Ther 50:438\u2013444. https:\/\/doi.org\/10.5414\/CP201641","journal-title":"Int J Clin Pharmacol Ther"},{"key":"3221_CR29","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1185\/03007995.2011.600300","volume":"27","author":"JR Zuniga","year":"2011","unstructured":"Zuniga JR, Noveck RJ, Schmidt WK et al (2011) Onset of action of diclofenac potassium liquid-filled capsules in dental surgery patients. Curr Med Res Opin 27:1733\u20131739. https:\/\/doi.org\/10.1185\/03007995.2011.600300","journal-title":"Curr Med Res Opin"},{"key":"3221_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4081\/REUMATISMO.2019.1188","volume":"71","author":"A Ariani","year":"2019","unstructured":"Ariani A, Manara M, Fioravanti A et al (2019) The Italian society for rheumatology clinical practice guidelines for the diagnosis and management of knee, hip and hand osteoarthritis. Reumatismo 71:5\u201321. https:\/\/doi.org\/10.4081\/REUMATISMO.2019.1188","journal-title":"Reumatismo"},{"key":"3221_CR31","doi-asserted-by":"publisher","unstructured":"Bally M, Dendukuri N, Rich B et al (2017) Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data. BMJ 357. https:\/\/doi.org\/10.1136\/BMJ.J1909","DOI":"10.1136\/BMJ.J1909"},{"key":"3221_CR32","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0140-6736(16)32404-7","volume":"390","author":"A Lanas","year":"2017","unstructured":"Lanas A, Chan FKL (2017) Peptic ulcer disease. Lancet 390:613\u2013624. https:\/\/doi.org\/10.1016\/S0140-6736(16)32404-7","journal-title":"Lancet"},{"key":"3221_CR33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2165\/00044011-200727030-00002","volume":"27","author":"N Moore","year":"2007","unstructured":"Moore N (2007) Diclofenac potassium 12.5\u00a0mg tablets for mild to moderate pain and fever: a review of its pharmacology, clinical efficacy and safety. Clin Drug Investig 27:163\u2013195. https:\/\/doi.org\/10.2165\/00044011-200727030-00002","journal-title":"Clin Drug Investig"},{"key":"3221_CR34","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/J.SEMARTHRIT.2015.11.009","volume":"45","author":"JP Pelletier","year":"2016","unstructured":"Pelletier JP, Martel-Pelletier J, Rannou F, Cooper C (2016) Efficacy and safety of oral NSAIDs and analgesics in the management of osteoarthritis: evidence from real-life setting trials and surveys. Semin Arthritis Rheum 45:S22\u2013S27. https:\/\/doi.org\/10.1016\/J.SEMARTHRIT.2015.11.009","journal-title":"Semin Arthritis Rheum"},{"key":"3221_CR35","doi-asserted-by":"publisher","unstructured":"Zhu X, Sang L, Wu D et al (2018) Effectiveness and safety of glucosamine and chondroitin for the treatment of osteoarthritis: A meta-analysis of randomized controlled trials. J Orthop Surg Res 13. https:\/\/doi.org\/10.1186\/S13018-018-0871-5","DOI":"10.1186\/S13018-018-0871-5"},{"key":"3221_CR36","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1211\/JPP\/61.10.0002","volume":"61","author":"N Volpi","year":"2009","unstructured":"Volpi N (2009) Quality of different chondroitin sulfate preparations in relation to their therapeutic activity. J Pharm Pharmacol 61:1271\u20131280. https:\/\/doi.org\/10.1211\/JPP\/61.10.0002","journal-title":"J Pharm Pharmacol"},{"key":"3221_CR37","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1007\/S10787-024-01460-9","volume":"32","author":"A Rabade","year":"2024","unstructured":"Rabade A, Viswanatha GL, Nandakumar K, Kishore A (2024) Evaluation of efficacy and safety of glucosamine sulfate, chondroitin sulfate, and their combination regimen in the management of knee osteoarthritis: a systematic review and meta-analysis. Inflammopharmacology 32:1759\u20131775. https:\/\/doi.org\/10.1007\/S10787-024-01460-9","journal-title":"Inflammopharmacology"},{"key":"3221_CR38","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1136\/ANNRHEUMDIS-2014-206792\/-\/DC1","volume":"75","author":"MC Hochberg","year":"2016","unstructured":"Hochberg MC, Martel-Pelletier J, Monfort J et al (2016) Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: A multicentre, randomised, double-blind, non-inferiority trial versus celecoxib. Ann Rheum Dis 75:37\u201344. https:\/\/doi.org\/10.1136\/ANNRHEUMDIS-2014-206792\/-\/DC1","journal-title":"Ann Rheum Dis"},{"key":"3221_CR39","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/S00296-009-0969-5","volume":"30","author":"YH Lee","year":"2010","unstructured":"Lee YH, Woo JH, Choi SJ et al (2010) Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis. Rheumatol Int 30:357\u2013363. https:\/\/doi.org\/10.1007\/S00296-009-0969-5","journal-title":"Rheumatol Int"},{"key":"3221_CR40","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/j.joca.2010.02.016","volume":"18","author":"MC Hochberg","year":"2010","unstructured":"Hochberg MC (2010) Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration. Osteoarthritis Cartilage 18:S28\u2013S31. https:\/\/doi.org\/10.1016\/j.joca.2010.02.016","journal-title":"Osteoarthritis Cartilage"},{"key":"3221_CR41","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1080\/14656566.2018.1442438","volume":"19","author":"O Bruy\u00e8re","year":"2018","unstructured":"Bruy\u00e8re O (2018) Pharmaceutical-grade chondroitin sulfate in the management of knee osteoarthritis. Expert Opin Pharmacother 19:409\u2013412. https:\/\/doi.org\/10.1080\/14656566.2018.1442438","journal-title":"Expert Opin Pharmacother"},{"key":"3221_CR42","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1136\/ANNRHEUMDIS-2016-210860","volume":"76","author":"JY Reginster","year":"2017","unstructured":"Reginster JY, Dudler J, Blicharski T, Pavelka K (2017) Pharmaceutical-grade chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the chondroitin versus celecoxib versus placebo trial (CONCEPT). Ann Rheum Dis 76:1537\u20131543. https:\/\/doi.org\/10.1136\/ANNRHEUMDIS-2016-210860","journal-title":"Ann Rheum Dis"},{"key":"3221_CR43","doi-asserted-by":"publisher","first-page":"179","DOI":"10.4078\/JRD.2019.26.3.179","volume":"26","author":"SK Cho","year":"2019","unstructured":"Cho SK, Kim H, Park HR et al (2019) Nonsteroidal Anti-inflammatory drugs-sparing effect of symptomatic Slow-acting drugs for osteoarthritis in knee osteoarthritis patients. J Rheumatic Dis 26:179\u2013185. https:\/\/doi.org\/10.4078\/JRD.2019.26.3.179","journal-title":"J Rheumatic Dis"},{"key":"3221_CR44","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1001\/ARCHINTE.163.13.1514","volume":"163","author":"F Richy","year":"2003","unstructured":"Richy F, Bruyere O, Ethgen O et al (2003) Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: A comprehensive Meta-analysis. Arch Intern Med 163:1514\u20131522. https:\/\/doi.org\/10.1001\/ARCHINTE.163.13.1514","journal-title":"Arch Intern Med"},{"key":"3221_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12891-022-06046-6\/TABLES\/1","volume":"23","author":"N Veronese","year":"2022","unstructured":"Veronese N, Ecarnot F, Cheleschi S et al (2022) Possible synergic action of non-steroidal anti-inflammatory drugs and glucosamine sulfate for the treatment of knee osteoarthritis: a scoping review. BMC Musculoskelet Disord 23:1\u20139. https:\/\/doi.org\/10.1186\/S12891-022-06046-6\/TABLES\/1","journal-title":"BMC Musculoskelet Disord"},{"key":"3221_CR46","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1136\/BMJ.C4675","volume":"341","author":"S Wandel","year":"2010","unstructured":"Wandel S, J\u00fcni P, Tendal B et al (2010) Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ 341:711. https:\/\/doi.org\/10.1136\/BMJ.C4675","journal-title":"BMJ"},{"key":"3221_CR47","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/IJCP.12115","volume":"67","author":"D Wu","year":"2013","unstructured":"Wu D, Huang Y, Gu Y, Fan W (2013) Efficacies of different preparations of glucosamine for the treatment of osteoarthritis: a meta-analysis of randomised, double-blind, placebo-controlled trials. Int J Clin Pract 67:585\u2013594. https:\/\/doi.org\/10.1111\/IJCP.12115","journal-title":"Int J Clin Pract"},{"key":"3221_CR48","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/J.RDC.2010.11.007","volume":"37","author":"KL Miller","year":"2011","unstructured":"Miller KL, Clegg DO (2011) Glucosamine and chondroitin sulfate. Rheumatic Disease Clin North Am 37:103\u2013118. https:\/\/doi.org\/10.1016\/J.RDC.2010.11.007","journal-title":"Rheumatic Disease Clin North Am"},{"key":"3221_CR49","doi-asserted-by":"publisher","DOI":"10.46856\/GRP.10.E072","author":"M Vitaloni","year":"2021","unstructured":"Vitaloni M, M\u00f6ller I, Verges J (2021) SYSADOAs: Su Origen y Calidad Hacen La diferencia En eficacia y seguridad? Global Rheumatol. https:\/\/doi.org\/10.46856\/GRP.10.E072","journal-title":"Global Rheumatol"}],"container-title":["Aging Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-025-03221-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40520-025-03221-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-025-03221-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T14:15:43Z","timestamp":1762438543000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40520-025-03221-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3221"],"URL":"https:\/\/doi.org\/10.1007\/s40520-025-03221-2","relation":{},"ISSN":["1720-8319"],"issn-type":[{"value":"1720-8319","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JYR has received consultancy fees and speaker bureau\u2019s honorarium from IBSA; LS was supported by MHCR 023728; all other authors declare no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"JYR has received consultancy fees and speaker bureau\u2019s honorarium from IBSA; LS was supported by MHCR 023728; all other authors declare no conflict of interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}],"article-number":"317"}}